Do not make unauthorized copies. Figure 2 . Low Dose Vigil Phase I Survival status. Arrow indicates subjects still alive. Figure 3 . Low Dose Vigil Phase I ELISPOT response status. Gray lines indicates time points off treatment. Ph III Ewing’s Sarcoma Vigil ± Irinotecan +Temozolomide IND 014205 CL-PTL-130 Version: 03 Page 24 of 74 Confidential and proprietary information of Gradalis, Inc. Effective: 05-DEC-2018 It is the user’s responsibility to verify adequate training before executing a document.